Insights

Stuart Bell, Vice President, Consulting, Inceptua Medicines Access In discussions with our clients over recent months the topic of ethics committee involvement in pre-approval access programs (expanded access, compassionate use,…

Typically, there are three ways in which patients can get access to a medicine; through a clinical trial, when it is commercially available, or via a pre-approval / unlicensed medicines…
News and Press Releases

Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group for Commercialization of Apealea® (Paclitaxel Micellar) in Europe December 28 2020, Elevar Therapeutics, Inc, a fully integrated biopharmaceutical company built…

LUXEMBOURG, Dec. 3, 2020 Inceptua announces that the company has entered into a partnership with Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company focused on discovering, developing and delivering treatments…

LUXEMBOURG – 25 September, 2020 – Inceptua Group – pharmaceutical company and service partner announces that the European Commission (EC) has approved the transfer of the marketing authorisation for Jetrea®…